Aminocaproic and Rashes - a phase IV clinical study of FDA data

Summary:

Rashes is reported as a side effect among people who take Aminocaproic (aminocaproic acid), especially for people who are male, 60+ old, also take Omeprazole, and have Myelodysplastic syndrome.

The phase IV clinical study analyzes which people have Rashes when taking Aminocaproic. It is created by eHealthMe based on reports of 735 people who have side effects when taking Aminocaproic from the FDA, and is updated regularly.

What is Aminocaproic?

Aminocaproic has active ingredients of aminocaproic acid. eHealthMe is studying from 737 Aminocaproic users. Check the latest studies of Aminocaproic.

What is Rashes?

Rashes (redness) is found to be associated with 3,714 drugs and 6,213 conditions by eHealthMe. Check the latest studies of Rashes.

On Aug, 11, 2026

735 people reported to have side effects when taking Aminocaproic.
Among them, 16 people (2.18%) have Rashes.

Among these 16 people:

What is the gender of people who have Rashes when taking Aminocaproic? *

female: 31.25 %
male: 68.75 %

What is the age of people who have Rashes when taking Aminocaproic? *

What are other drugs people take besides Aminocaproic? *

Omeprazole: 4 people, 25.00%
Lisinopril: 3 people, 18.75%
Vancomycin: 3 people, 18.75%
Magnesium Sulfate: 3 people, 18.75%
Exjade: 3 people, 18.75%
Gabapentin: 3 people, 18.75%
Acetaminophen: 3 people, 18.75%
Heparin: 2 people, 12.50%
Metoprolol Tartrate: 2 people, 12.50%
Nicardipine Hydrochloride: 2 people, 12.50%

What are other side effects people have besides Rashes? *

Dyspnea (difficult or laboured breathing): 3 people, 18.75%
Urticaria (rash of round, red welts on the skin that itch intensely): 3 people, 18.75%
Heart Rate Increased: 2 people, 12.50%
Hot Flush (sudden feelings of heat): 2 people, 12.50%
Swelling: 2 people, 12.50%
Blood Lactate Dehydrogenase Increased: 2 people, 12.50%
Hypotension (abnormally low blood pressure): 2 people, 12.50%
Fever: 1 person, 6.25%
Feeling Hot: 1 person, 6.25%
Febrile Neutropenia (fever with reduced white blood cells): 1 person, 6.25%

What are the existing conditions these people have? *

Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 3 people, 18.75%
Taste - Impaired: 1 person, 6.25%
Haemorrhage (bleeding): 1 person, 6.25%
Cancer Pain: 1 person, 6.25%
Cellulitis (infection under the skin): 1 person, 6.25%
Constipation: 1 person, 6.25%
Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 1 person, 6.25%
Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it): 1 person, 6.25%
Dermatitis Acneiform (dermatoses including acne vulgaris, rosacea, folliculitis, and perioral dermatitis): 1 person, 6.25%
Fever: 1 person, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Aminocaproic and have Rashes?

- Check whether Rashes is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Aminocaproic:

Aminocaproic (737 reports)

Rashes treatments and more:

Rashes (702,909 reports)

Browse all side effects of Aminocaproic:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Rashes:

Rashes (3,714 drugs)

Browse all the conditions that are associated with Rashes:

Rashes (6,213 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on aminocaproic acid (the active ingredients of Aminocaproic) and Aminocaproic (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.